Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMPNPF0)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Benfluorex hydrochloride; 23642-66-2; Mediaxal; Lipophoral; Balans; Benfluorex (hydrochloride); EINECS 245-801-8; 2-((1-(3-(Trifluoromethyl)phenyl)propan-2-yl)amino)ethyl benzoate hydrochloride; NCGC00094832-01; 2-(alpha-Methyl-3-(trifluoromethyl)phenylethylamino)ethyl benzoat; DSSTox_CID_25854; DSSTox_RID_81175; DSSTox_GSID_45854; W-110575; 2-((alpha-Methyl-m-(trifluoromethyl)phenethyl)amino)ethanol benzoate (ester); Benfluorex HCl; 2-{(1-METHYL-2-[3-(TRIFLUOROMETHYL)PHENYL]ETHYL}AMINO)ETHYL BENZOATE HYDROCHLORIDE
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||
|
|||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
Breast
Breast adenocarcinoma
Cervix
Cervical adenocarcinoma
Colon
Colorectal adenocarcinoma
Kidney
Normal (Immortalized)
Pancreas
Pancreatic carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
